‘The dilemmas of breast cancer treatment and increased fracture risk’ by Malik

‘The dilemmas of breast cancer treatment and increased fracture risk’ by Malik

We read with interest the letter ‘the dilemmas of breast cancer treatment and increased fracture risk’ by Malik [1] and thank him to his attention to our article [2].We would like to add some commentaries. As mentioned in the initial article describing the baseline characteristics of the patients of...

Full description

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 25; no. 8; pp. 1664 - 1665
Main Authors: Bouvard, B., Legrand, E.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-08-2014
Elsevier
Subjects:
Aromatase Inhibitors - adverse effects
Breast Neoplasms - drug therapy
Female
Fractures, Bone - chemically induced
Humans
Life Sciences
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We read with interest the letter ‘the dilemmas of breast cancer treatment and increased fracture risk’ by Malik [1] and thank him to his attention to our article [2].We would like to add some commentaries. As mentioned in the initial article describing the baseline characteristics of the patients of our cohort [3], 920 women with breast cancer were examined between January 2006 and January 2009. Among them, 615 women with a tumor expressing estrogen receptor were treated by aromatase inhibitor (AI) therapy. 530 women without bone metastasis agreed to have an osteoporosis assessment within the first 3 months of AI therapy and finally 497 women without bone medication were included. Among …
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdu222